Integration of the extranuclear and nuclear actions of estrogen

被引:557
作者
Levin, ER [1 ]
机构
[1] Vet Affairs Med Ctr, Div Endocrinol, Long Beach, CA 90822 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA
[3] Univ Calif Irvine, Dept Biochem, Irvine, CA 92717 USA
[4] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA
关键词
D O I
10.1210/me.2004-0390
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Estrogen receptors (ERs) are localized to many sites within the cell, potentially contributing to overall estrogen action. In the nucleus, estrogen mainly modulates gene transcription, and the resulting protein products determine the cell biological actions of the sex steroid. In addition, a small pool of ERs localize to the plasma membrane and signal mainly though coupling, directly or indirectly, to G proteins. In response to steroid, signal transduction modulates both nontranscriptional and transcriptional events and impacts both the rapid and more prolonged actions of estrogen. Cross-talk from membrane-localized ERs to nuclear ERs can be mediated through growth factor receptor tyrosine kinases, such as epidermal growth factor receptor and IGF-I receptor. Growth factor receptors enact signal transduction to kinases such as ERK and phosphatidylinositol 3-kinase that phosphorylate and activate nuclear ERs, and this can also occur in the absence of sex steroid. A complex relationship between the membrane and nuclear effects of estrogen also involves membrane-initiated phosphorylation of coactivators, recruiting these proteins to the nuclear transcriptosome. Finally, large pools of cytoplasmic ERs exist, and some are localized to mitochondria. The integration of sex steroid effects at distinct cellular locations of its receptor leads to important cellular physiological outcomes and are manifest in both reproductive and nonreproductive organs.
引用
收藏
页码:1951 / 1959
页数:9
相关论文
共 99 条
[1]   Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain [J].
Abrahám, IM ;
Todman, MG ;
Korach, KS ;
Herbison, AE .
ENDOCRINOLOGY, 2004, 145 (07) :3055-3061
[2]   Palmitoylation-dependent estrogen receptor α membrane localization:: Regulation by 17β-estradiol [J].
Acconcia, F ;
Ascenzi, P ;
Bocedi, A ;
Spisni, E ;
Tomasi, V ;
Trentalance, A ;
Visca, P ;
Marino, M .
MOLECULAR BIOLOGY OF THE CELL, 2005, 16 (01) :231-237
[3]   S-palmitoylation modulates human estrogen receptor-α functions [J].
Acconcia, F ;
Ascenzi, P ;
Fabozzi, G ;
Visca, P ;
Marino, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (03) :878-883
[4]   G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells [J].
Ahola, TM ;
Manninen, T ;
Alkio, N ;
Ylikomi, T .
ENDOCRINOLOGY, 2002, 143 (09) :3376-3384
[5]   Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells [J].
Balasenthil, S ;
Barnes, CJ ;
Rayala, SK ;
Kumar, R .
FEBS LETTERS, 2004, 567 (2-3) :243-247
[6]  
Bartucci M, 2001, CANCER RES, V61, P6747
[7]   Oestrogen as a neuroprotective hormone [J].
Behl, C .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (06) :433-442
[8]   Estradiol signaling via sequestrable surface receptors [J].
Benten, WPM ;
Stephan, C ;
Lieberherr, M ;
Wunderlich, F .
ENDOCRINOLOGY, 2001, 142 (04) :1669-1677
[9]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[10]   Dissecting the basis of nongenomic activation of endothelial nitric oxide synthase by estradiol:: Role of ERα domains with known nuclear functions [J].
Chambliss, KL ;
Simon, L ;
Yuhanna, IS ;
Mineo, C ;
Shaul, PW .
MOLECULAR ENDOCRINOLOGY, 2005, 19 (02) :277-289